269 related articles for article (PubMed ID: 37491235)
1. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
[TBL] [Abstract][Full Text] [Related]
2. Association of coffee consumption and striatal volume in patients with Parkinson's disease and healthy controls.
Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Huang P; Xu X; Zhang M
CNS Neurosci Ther; 2023 Oct; 29(10):2800-2810. PubMed ID: 37032638
[TBL] [Abstract][Full Text] [Related]
3. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
[TBL] [Abstract][Full Text] [Related]
4. Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease.
Gigante AF; Asabella AN; Iliceto G; Martino T; Ferrari C; Defazio G; Rubini G
Neurol Sci; 2018 Mar; 39(3):551-555. PubMed ID: 29362953
[TBL] [Abstract][Full Text] [Related]
5. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
[TBL] [Abstract][Full Text] [Related]
6. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P
Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease.
Muñoz-Delgado L; Labrador-Espinosa MÁ; Macías-García D; Jesús S; Benítez Zamora B; Fernández-Rodríguez P; Adarmes-Gómez AD; Reina Castillo MI; Castro-Labrador S; Silva-Rodríguez J; Carrillo F; García Solís D; Grothe MJ; Mir P
Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400
[TBL] [Abstract][Full Text] [Related]
8. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
[TBL] [Abstract][Full Text] [Related]
9. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
10. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
[TBL] [Abstract][Full Text] [Related]
11. Dopamine Transporter Availability in Early Parkinson's Disease is Dependent on Sunlight Exposure.
Booij J; Tellier SP; Seibyl J; Vriend C
Mov Disord; 2023 Nov; 38(11):2131-2135. PubMed ID: 37670567
[TBL] [Abstract][Full Text] [Related]
12. Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis.
Lee JY; Lao-Kaim NP; Pasquini J; Deuschl G; Pavese N; Piccini P
Parkinsonism Relat Disord; 2018 Jun; 51():101-104. PubMed ID: 29503156
[TBL] [Abstract][Full Text] [Related]
13. Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson's disease.
Sampedro F; Marín-Lahoz J; Martínez-Horta S; Camacho V; Lopez-Mora DA; Pagonabarraga J; Kulisevsky J
Neurobiol Aging; 2021 Jan; 97():120-128. PubMed ID: 33212336
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
[TBL] [Abstract][Full Text] [Related]
15. Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease.
Jaakkola E; Joutsa J; Mäkinen E; Johansson J; Kaasinen V
Eur J Neurol; 2017 Nov; 24(11):1341-1347. PubMed ID: 28834102
[TBL] [Abstract][Full Text] [Related]
16. The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism.
Lee YH; Lee S; Chung SJ; Yoo HS; Jung JH; Baik K; Ye BS; Sohn YH; Yun M; Lee PH
Parkinsonism Relat Disord; 2021 Jan; 82():1-6. PubMed ID: 33220520
[TBL] [Abstract][Full Text] [Related]
17. Physical activity mediates the association between striatal dopamine transporter availability and cognition in Parkinson's disease.
Shih CH; Moore K; Browner N; Sklerov M; Dayan E
Parkinsonism Relat Disord; 2019 May; 62():68-72. PubMed ID: 30722964
[TBL] [Abstract][Full Text] [Related]
18. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
Hinkle JT; Perepezko K; Mills KA; Mari Z; Butala A; Dawson TM; Pantelyat A; Rosenthal LS; Pontone GM
Parkinsonism Relat Disord; 2018 Oct; 55():8-14. PubMed ID: 30146185
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
[TBL] [Abstract][Full Text] [Related]
20. Association between heart rate variability and striatal dopamine depletion in Parkinson's disease.
Kitagawa T; Umehara T; Oka H; Shiraishi T; Sato T; Takatsu H; Nakahara A; Matsuno H; Bono K; Omoto S; Murakami H; Sengoku R; Iguchi Y
J Neural Transm (Vienna); 2021 Dec; 128(12):1835-1840. PubMed ID: 34559319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
